A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

NCT02059616 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Amlodipine 5mg
DRUG: Amlodipine 10mg
DRUG: Candesartan Cilexetil 8mg
DRUG: Candesartan cilexetil 16mg

Sponsor

HK inno.N Corporation